TrialThe oncologist2019

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

David R D'Adamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.